-
ARM plans to cancel license for Qualcomm chips, intensifying dispute between two parties
ARM plans to cancel its license for Qualcomm chips, intensifying the dispute between the two sides. ARM sues Qualcomm, accusing it of breach of contract in 2022. -
Novo Nordisk reaches settlement with Mylan Pharmaceuticals over patent dispute over weight loss drug Ozempic and Wegovy
Novo Nordisk has reached a settlement with Mylan Pharmaceuticals regarding the patent dispute over the weight loss drugs Ozempic and Wegovy. Novo Nordisk and Mylan Pharmaceuticals, a subsidiary of Vi ... -
Will the sales director of Novo Nordisk protest due to emotional disputes? Company response: Personal dispute
Recently, a video of Cheng, the sales director of Novo Nordisk China, being protested by a woman in red at an academic conference has been circulating online, causing heated discussions. Afterwards, ...